Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb;14(2):81-100.
doi: 10.1016/S1875-5364(16)60002-X.

Bitter melon: a panacea for inflammation and cancer

Affiliations
Review

Bitter melon: a panacea for inflammation and cancer

Prasad R Dandawate et al. Chin J Nat Med. 2016 Feb.

Abstract

Nature is a rich source of medicinal plants and their products that are useful for treatment of various diseases and disorders. Momordica charantia, commonly known as bitter melon or bitter gourd, is one of such plants known for its biological activities used in traditional system of medicines. This plant is cultivated in all over the world, including tropical areas of Asia, Amazon, east Africa, and the Caribbean and used as a vegetable as well as folk medicine. All parts of the plant, including the fruit, are commonly consumed and cooked with different vegetables, stir-fried, stuffed or used in small quantities in soups or beans to give a slightly bitter flavor and taste. The plant is reported to possess anti-oxidant, anti-inflammatory, anti-cancer, anti-diabetic, anti-bacterial, anti-obesity, and immunomodulatory activities. The plant extract inhibits cancer cell growth by inducing apoptosis, cell cycle arrest, autophagy and inhibiting cancer stem cells. The plant is rich in bioactive chemical constituents like cucurbitane type triterpenoids, triterpene glycosides, phenolic acids, flavonoids, essential oils, saponins, fatty acids, and proteins. Some of the isolated compounds (Kuguacin J, Karaviloside XI, Kuguaglycoside C, Momordicoside Q-U, Charantin, α-eleostearic acid) and proteins (α-Momorcharin, RNase MC2, MAP30) possess potent biological activity. In the present review, we are summarizing the anti-oxidant, anti-inflammatory, and anti-cancer activities of Momordica charantia along with a short account of important chemical constituents, providing a basis for establishing detail biological activities of the plant and developing novel drug molecules based on the active chemical constituents.

Keywords: Anti-cancer activity; Anti-inflammatory activity; Anti-oxidant activity; Bitter melon; Momordica charantia; Natural products.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interests to disclose.

Figures

Fig. 1
Fig. 1
Pictures of Momordica charantia (Indian Variety) fruit (A), vertical section of the fruit (B), closer view of the fruit (C), and transverse section of the fruit (D)
Fig. 2
Fig. 2
Chemical structures of cucurbitane type triterpenoids isolated from Momordica charantia
Fig. 3
Fig. 3
Chemical structures of cucurbitane type triterpene glycoside isolated from Momordica charantia
Fig. 4
Fig. 4
Chemical structures of phenolic acids and flavonoids isolated from Momordica charantia
Fig. 5
Fig. 5
Chemical structures of essential oils isolated from Momordica charantia
Fig. 6
Fig. 6
Chemical structures of saponins and fatty acids isolated from Momordica charantia
Fig. 7
Fig. 7
Chemical structure of charantin

References

    1. Traditional Medicine Strategy Launched (WHO News) [M] WHO; 2002. p. 610.
    1. Patwardhan B, Warude D, Pushpangadan P, et al. Ayurveda and traditional Chinese medicine: a comparative overview [J] Evid Based Complement Alternat Med. 2005;2(4):465–473. - PMC - PubMed
    1. Nkambo W, Anyama N, Onegi B. In vivo hypoglycemic effect of methanolic fruit extract of Momordica charantia L [J] Afr Health Sci. 2013;13(4):933–939. - PMC - PubMed
    1. Kwatra D, Subramaniam D, Ramamoorthy P, et al. Methanolic extracts of bitter melon inhibit colon cancer stem cells by affecting energy homeostasis and autophagy [J] Evid Based Complement Alternat Med. 2013;2013:702869. - PMC - PubMed
    1. Zhang DW, Fu M, Gao SH, et al. Curcumin and diabetes: a systematic review [J] Evid Based Complement Alternat Med. 2013;2013:636053. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources